Regulatory Roundup: Commissioner Hamburg Says China is Improving Export Regulation

While visiting China last week, US Food and Drug Administration Commissioner Margaret Hamburg told the Associated Press that China is improving its oversight of exporters and that the two countries are pursuing a common agenda to improve manufacturing practices and supply-chain regulation. Chinese drug manufacturers and suppliers have been tied to numerous instances of contamination and adulteration in food and drug products during the past few years. FDA has been operating three offices in China (Shanghai, Beijing, and Guangzhou) since November 2008 to assist the country’s State Food and Drug Administration with inspections and training.